Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1859-1866, September 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kit, S.
Right arrow Articles by Dubbs, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kit, S.
Right arrow Articles by Dubbs, D. R.

Arabinofuranosylcytosine-induced Stimulation of Thymidine Kinase and Deoxycytidylic Deaminase Activities of Mammalian Cultures1

Saul Kit, R. A. de Torres2 and D. R. Dubbs

Division of Biochemical Virology, Baylor University College of Medicine, Houston, Texas

1-ß-D-Arabinofuranosylcytosine (ara-C) inhibited growth of monkey kidney, LM, LM(TK-), and HeLa cells and inhibited DNA biosynthesis in monkey kidney and LM cell cultures.

The thymidine (TdR) kinase activities of green monkey kidney (GMK or CV-1) and HeLa, but not LM or LM(TK-), cell cultures were greatly increased after ara-C treatment. A smaller increase of deoxycytidylic (dCMP) deaminase, but not of the thymidylic (TMP) kinase activity, was also found. The induction of TdR kinase activity by ara-C was prevented by cycloheximide.

Addition to the cultures of arabinofuranosylthymine (ara-T), arabinofuranosyluracil (ara-U), TdR, deoxyuridine (UdR), or cytidine did not produce increases in the TdR kinase activity comparable to those produced by ara-C treatment, and the addition of TdR, UdR, or cytidine to cultures treated with ara-C did not alter the ara-C-induced stimulation of TdR kinase.

Ara-T, ara-U, and ara-C did not inhibit either the enzymatic phosphorylation of UdR-3H or the deamination of dCMP-3H. Deoxycytidine, when added to cultures at the same time as ara-C, prevented the increase in TdR kinase and, when added 24 hr after the ara-C treatment, reversed the ara-C induction of TdR kinase.

Mitomycin C (15–25 µg/ml), another inhibitor of DNA biosynthesis, induced about a 4-fold increase in the TdR kinase activity. However, TdR kinase activity was not stimulated in cultures treated with 50 or 100 µg/ml mitomycin C.

1 This investigation was aided by grants from the National Science Foundation (GB 3126), the American Cancer Society (E 291), and by USPHS Grants CA-06656, 1-K6-AI-2352, and 1-K3-CA-25, 797.

2 Postdoctoral Fellow of the Consejo Nacional de Investigaciones Científicas y Téenicas (Argentina).

Received 2/ 9/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.